Pluri Prices $3.3M Offering at $1.47, Deepening Dilution Near 52-Week Low
PLUR is trading near its 52-week low of $1.45 (1.4% above the low) on elevated volume (3.5× avg).
Summary
Pluri priced a $3.3 million registered direct offering and concurrent private placement with a single healthcare-focused institutional investor. The offering comes as the stock trades near its 52-week low of $1.45, with a market cap of roughly $16 million. This follows a series of liquidity events: a $1.25 million advance from the chairman in June, a Nasdaq delisting notice in July, and an EIB loan deferral. The new capital is highly dilutive relative to the company's size and signals continued cash strain. The offering consists of 1,200,000 shares at $1.50 and pre-funded warrants for 1,028,940 shares at $1.49999, plus common warrants for 2,228,940 shares at $1.65, with net proceeds of about $2,984,808.
Updated with an SEC 8-K filing · What changed
Updates
· SEC 8-K — The 8-K details the offering: 1,200,000 shares at $1.50 and pre-funded warrants for 1,028,940 shares at $1.49999, plus common warrants for 2,228,940 shares at $1.65, with net proceeds of about $2,984,808.
At the time of this announcement, PLUR was trading at $1.47 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $16M. The 52-week trading range was $1.45 to $5.68. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.